Oric Pharmaceuticals Inc (ORIC)

Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	7.76% 28.99	31.43	28.68	24.99	25.68
Operating Income/Loss	7.76% -28.99	-31.43	-28.68	-24.99	-25.68
Nonoperating Income/Loss	28.44% 3.979	3.098	3.204	2.048	1.733
Income/Loss From Continuing Operations Before Tax	11.72% -25.01	-28.33	-25.48	-22.94	-23.95
Income/Loss From Continuing Operations After Tax	11.72% -25.01	-28.33	-25.48	-22.94	-23.95
Net Income/Loss	11.72% -25.01	-28.33	-25.48	-22.94	-23.95
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,224% 67.35	2.0264	57.40	45.65	45.09
Diluted Average Shares	3,224% 67.35	2.0264	57.40	45.65	45.09
Basic Earnings Per Share	26.00% -0.37	-0.50	-0.44	-0.50	-0.53
Diluted Earnings Per Share	26.00% -0.37	-0.50	-0.44	-0.50	-0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-